<DOC>
	<DOCNO>NCT00098384</DOCNO>
	<brief_summary>The purpose study evaluate effectiveness poorly absorb rifaximin prevention traveler ' diarrhea among U.S. college student Mexico five week .</brief_summary>
	<brief_title>Rifaximin Versus Placebo Prevention Travelers ' Diarrhea</brief_title>
	<detailed_description>This investigator-initiated proposal wherein 220 male female subject &gt; 17 year age industrialize region randomize receive poorly absorb antibiotic , rifaximin , one three dos mealtime ( expose diarrhea-causing bacteria ) , 200 mg day , 200 mg twice day 200 mg three time day versus placebo start arrival ( within first 72 hour ) Mexico continue two week diary symptom record three week . Adverse event subject follow five week . If mild diarrhea ( 1 2 unformed stools/24 hour plus enteric symptom ) diarrheal illness ( &gt; 2 unformed stools/24 hour plus enteric symptom ) develop , subject provide stool sample determine cause illness . Forty subject provide stool sample 7 day 14 day treatment see intestinal bacterial flora develop resistance rifaximin see level drug achieve . Stool sample forty subject study enteric pathogen look asymptomatic infection period prophylaxis . The stool sample collect initially process enteric laboratory Guadalajara , Mexico . Specialized test study toxigenicity enterotoxigenic E. coli enteroadherence enteroaggregative E. coli do Houston .</detailed_description>
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Dysentery</mesh_term>
	<mesh_term>Rifaximin</mesh_term>
	<mesh_term>Rifamycins</mesh_term>
	<criteria>An Investigational Review Board approve , write informed consent appropriately witness , sign date prior studyrelated activity Male female subject 18 year age older Able read understand English Enrolled start prophylaxis within 72 hour arrival Mexico If subject female , woman nonchildbearing potential pregnant eligible . Urine pregnancy test perform woman question pregnancy status . Women study require employ reliable method contraception take medication . Forms acceptable contraception include : Double barrier method contraception . Oral birth control pill least two cycle enrollment continue therapy – subject tell use barrier contraception method study well . Norplant insert least one month enrollment . An intrauterine device insert qualified clinician . Medroxyprogesterone acetate minimum one month study administer one month follow study completion . An approved birth control patch least two cycle enrollment continue therapy . OR Complete abstinence intercourse two week medication . Acute diarrhea ( criteria traveler ’ diarrhea ) within past week Diarrhea develop within 24 hour study enrollment In Mexico 72 hour Receipt one follow class drug : fluoroquinolone ( drug class ) , macrolide azalide trimethoprimsulfamethoxazole within past week three week study Receipt medication decrease occurrence diarrhea ( e.g . bismuth subsalicylate lactobacillus preparation ) For female , pregnancy breast feeding three week study Receipt antidiarrheal medication ( loperamide , bismuth subsalicylate , kaopectate ) within 24 hour enrollment Hypersensitivity rifaximin Unstable medical condition include chronic renal failure insulin dependent diabetes .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2004</verification_date>
	<keyword>Travelers ’ diarrhea</keyword>
	<keyword>rifaximin</keyword>
	<keyword>prophylaxis</keyword>
	<keyword>enterotoxigenic E. coli</keyword>
</DOC>